RNA Therapies in Liver Disease: Insights from Ochre Bio’s CEO

In this interview, we speak with Jack O’Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O’Meara shares insights into Ochre Bio’s innovative RNA therapies, their approach to tackling liver disease, and the company’s vision for the future.

Andre Braugher’s Cancer Dx; Malignancies Rising in Younger Adults; Negative Trials

Actor Andre Braugher, who passed away this week at the age of 61, was diagnosed with lung cancer a few months ago, according to his

December 15, 2023

Pelago raises $58M to expand online substance use treatment

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Pelago, which provides digital substance use treatment

March 29, 2024

Study links brisk walking to lower type 2 diabetes risk

A recent study in the British Journal of Sports Medicine reveals that brisk walking significantly reduces the risk of type 2 diabetes. The systematic review

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.